These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 33948367)
1. MEX3A suppresses proliferation and EMT via inhibiting Akt signaling pathway in cervical cancer. Xu Y; Pan S; Chen H; Qian H; Wang Z; Zhu X Am J Cancer Res; 2021; 11(4):1446-1462. PubMed ID: 33948367 [TBL] [Abstract][Full Text] [Related]
2. Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA/ROCK1/LIMK1 signaling pathway. Yan L; Li H; An W; Wei W; Zhang X; Wang L Bioengineered; 2021 Dec; 12(1):5850-5858. PubMed ID: 34486491 [TBL] [Abstract][Full Text] [Related]
3. MEX3A knockdown inhibits the tumorigenesis of colorectal cancer via modulating CDK2 expression. Zhou X; Li S; Ma T; Zeng J; Li H; Liu X; Li F; Jiang B; Zhao M; Liu Z; Qin Y Exp Ther Med; 2021 Nov; 22(5):1343. PubMed ID: 34630697 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling. Zou C; Fan J; He M; Xu Y; Wang K; Cai Y; Li M Exp Cell Res; 2019 May; 378(2):139-148. PubMed ID: 30826396 [TBL] [Abstract][Full Text] [Related]
5. The effects of MEX3A knockdown on proliferation, apoptosis and migration of osteosarcoma cells. Wang B; Hong Z; Zhao C; Bi Q; Yuan J; Chen J; Shen Y Cancer Cell Int; 2021 Apr; 21(1):197. PubMed ID: 33827584 [TBL] [Abstract][Full Text] [Related]
6. DYNLT3 overexpression induces apoptosis and inhibits cell growth and migration Zhang J; Shen Q; Xia L; Zhu X; Zhu X Front Oncol; 2022; 12():889238. PubMed ID: 35965516 [TBL] [Abstract][Full Text] [Related]
7. MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway. Jiang S; Meng L; Chen X; Liu H; Zhang J; Chen F; Zheng J; Liu H; Wang F; Hu J; Li Z Exp Cell Res; 2020 Oct; 395(2):112191. PubMed ID: 32738346 [TBL] [Abstract][Full Text] [Related]
8. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway. Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway. Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485 [TBL] [Abstract][Full Text] [Related]
10. MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma. Wang X; Shan YQ; Tan QQ; Tan CL; Zhang H; Liu JH; Ke NW; Chen YH; Liu XB Cancer Cell Int; 2020; 20():63. PubMed ID: 32140076 [TBL] [Abstract][Full Text] [Related]
11. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis. Hu S; Duan YX; Zhou Q; Wang Y; Lu Q IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway. Zhang Y; Li Y Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272 [TBL] [Abstract][Full Text] [Related]
13. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer. Luo F; Zhao Y; Liu J Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280 [TBL] [Abstract][Full Text] [Related]
14. TM7SF2 regulates cell proliferation and apoptosis by activation of C-Raf/ERK pathway in cervical cancer. Xu Y; Chen X; Pan S; Wang ZW; Zhu X Cell Death Discov; 2021 Oct; 7(1):299. PubMed ID: 34667152 [TBL] [Abstract][Full Text] [Related]
15. miR-636 inhibits EMT, cell proliferation and cell cycle of ovarian cancer by directly targeting transcription factor Gli2 involved in Hedgehog pathway. Ma J; Zhou C; Chen X Cancer Cell Int; 2021 Jan; 21(1):64. PubMed ID: 33472614 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway. Li YM; Li XJ; Yang HL; Zhang YB; Li JC Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295 [TBL] [Abstract][Full Text] [Related]
17. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway. Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition. Song R; Zhang J; Huang J; Hai T Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220 [TBL] [Abstract][Full Text] [Related]
19. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway. Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503 [TBL] [Abstract][Full Text] [Related]
20. FZD2 promotes TGF-β-induced epithelial-to-mesenchymal transition in breast cancer via activating notch signaling pathway. Tuluhong D; Chen T; Wang J; Zeng H; Li H; Dunzhu W; Li Q; Wang S Cancer Cell Int; 2021 Apr; 21(1):199. PubMed ID: 33832493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]